Powering the Immune System to Transform Lives

Sasha Damouni Ellis photoSasha Damouni Ellis


Sasha Damouni Ellis has served as Vir’s Executive Vice President and Chief Corporate Affairs Officer since July 2023. Ms. Damouni Ellis brings close to 20 years’ experience in the healthcare industry, with expertise in financial communications, issues management, investor relations, patient advocacy and media relations.

Prior to Vir, Ms. Damouni Ellis was Senior Vice President, Corporate Affairs and Investor Relations at Marinus Pharmaceuticals. She was previously Director of External Communications and Media Relations for Bayer U.S., where she drove external brand-building strategies in therapeutic areas of oncology, hemophilia, cardio-pulmonary and women’s health. Earlier in her career, Ms. Damouni Ellis was a Senior Healthcare Journalist at Bloomberg News and Global Editor of BioPharm Insight, formerly a division of the Financial Times Group, which she launched in New York and London. She has held editorial roles at Mergermarket and a number of leading international newspapers. 

Ms. Damouni Ellis earned her Master of Arts from City, University of London’s Graduate School of Journalism, in the United Kingdom, and her Bachelor of Arts Degree from Richmond, the American International University in London, United Kingdom.